Tscan Therapeutics (TCRX) Q4 2023 Earnings

6MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.03
-0.69
-0.34
0

Details

Expected EPS
-0.289167
Actual EPS
-0.21
Surprise EPS
0.08
Surprise Percent
+27.38%

Description

Tscan Therapeutics (TCRX) has reported earnings of -0.21 per share for Q4 2023.

0 Comments

Share your thoughts